News
March 18, 2019
Study Evaluates Two Drug Therapies on Children with Lupus Nephritis
Today, lupus treatment in children is based on research conducted on adults. A new study analyzed treatment response, damage accrual, and disease activity in 51 children (16 years old or younger) with juvenile-onset lupus nephritis. The study analyzed data collected from juveniles who were treated with mycophenolate mofetil (a drug that prevents organ rejection) or cyclophosphamide (a drug used to treat nephrotic syndrome). While there were no statistically significant differences identified between the two therapies, researchers concluded that further study should include children with ethnically diverse backgrounds. Ultimately, more research in children with lupus nephritis is needed. Learn about lupus and children.
See More:
The latest from Inside Lupus Research
Experimental Treatment, Zetomipzomib, for Lupus Nephritis to be Developed and Marketed in Asia
News
New Study Examines the Benefits of Ginger Supplements in Autoimmune Diseases Like Lupus
News
Predictors for the Development of Systemic Lupus Erythematosus in People with Sjogren’s Syndrome
News
$3 Million Grant Awarded to Develop Artificial Intelligence to Help Diagnose Lupus Nephritis
News